Amphastar Pharmaceuticals Inc vs SoundHound AI Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while SoundHound AI Inc trades at $7.48 (market cap $3.29B). The key difference: SoundHound AI Inc is far larger — about 3.8× Amphastar Pharmaceuticals Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | SOUN | |
|---|---|---|
Market Cap | $868.62M | $3.29B |
Sector | Health | Technology |
52-Week High | $30.81 | $21.40 |
52-Week Low | $16.87 | $5.70 |
Enterprise Value | $1.27B | $3.09B |
Trailing returns across standard periods
Latest headlines on both assets
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →